


This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. Featuring expert presentations and a panel discussion, the summit will explore topics such as how to tackle cancer drug resistance, personalised medicine, cytotoxic therapy in the immunotherapy… Read More

News round-up for 21-25 September 2026 by Megan Thomas, Content Team at DDW. This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, as well as the latest developments in drug discovery,… Read More

Early bird rates for the Drug Discovery Innovators & Investors (DDII) UK Conference close on 30 September 2026. Taking place on 4 November 2026 at etc.venues Monument in London, UK, the conference brings together pharma and biotech companies, technology suppliers, academia, start-ups, spin-outs and investors for a focused day of… Read More

Stacey Willard, Vice President of Marketing and Product Management at Nuclera, explores the validation bottleneck for antibody engineering and why generative AI may be the answer to this challenge. Antibody engineering has developed a pronounced asymmetry. AI can now generate and rank antibody candidates at a pace that conventional experimental… Read More

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More

Dr James Heward, VP Functional Genomics at Nucleome Therapeutics, discusses what could be the missing link in the chain of causality from patient to target to drug. The fundamental question that stalks every drug discovery project is “will this drug fail?” Most do. There is no single reason for more than 90% of clinical… Read More

A new resource is now available to download for free. Efficient assay preparation and reliable affinity measurements are critical to successful screening campaigns. This technical note explores how Dianthus uHTS can be integrated with Echo Acoustic Liquid Handling to support automated, miniaturised affinity screening workflows. Download the App Note to… Read More

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More

News round-up for 14-18 September 2026 by Megan Thomas, Content Team at DDW. This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, changes to US scientific research grant screening, the UK’s… Read More


US researchers have filed a class action lawsuit challenging the National Institutes of Health’s (NIH) policy of blocking grants to censor views it disagrees with, on everything from DEI to gender identity to climate change. The plaintiffs are represented by the American Civil Liberties Union, the ACLU… Read More


Experts from across the drug discovery ecosystem will explore the technologies, strategies, therapies and investment trends shaping early-stage drug discovery at the Drug Discovery Innovators & Investors (DDII) Digital Forum on 30 September. The Forum is free to attend. Register for the full event, or simply join one of the… Read More